Stocks and Investing Stocks and Investing
Wed, September 30, 2020
Tue, September 29, 2020
Mon, September 28, 2020
Sat, September 26, 2020
Fri, September 25, 2020
Thu, September 24, 2020
Wed, September 23, 2020
Tue, September 22, 2020
Mon, September 21, 2020

Michael Wiederhorn Maintained (AMED) at Buy with Increased Target to $260 on, Sep 21st, 2020


Published on 2024-10-27 13:33:19 - WOPRAI
  Print publication without navigation


Michael Wiederhorn of Oppenheimer, Maintained "Amedisys, Inc." (AMED) at Buy with Increased Target from $250 to $260 on, Sep 21st, 2020.

Michael has made no other calls on AMED in the last 4 months.



There are 5 other peers that have a rating on AMED. Out of the 5 peers that are also analyzing AMED, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matt Borsch of "BMO Capital" Maintained at Hold with Increased Target to $270 on, Wednesday, September 2nd, 2020


These are the ratings of the 4 analyists that currently disagree with Michael


  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Increased Target to $250 on, Thursday, July 30th, 2020
  • Frank Morgan of "RBC Capital" Maintained at Buy with Increased Target to $260 on, Thursday, July 30th, 2020
  • John Ransom of "Raymond James" Maintained at Buy with Increased Target to $255 on, Thursday, July 30th, 2020
  • Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $260 on, Thursday, July 30th, 2020

Similar Stocks and Investing Articles